Ultrasensitive Insulin ELISA

$423.00
Catalog
80-INSHUU-E01.1

The Ultrasensitive Insulin ELISA quantifies the concentration of insulin protein in human serum or plasma samples. FDA Class I Device. For In Vitro Diagnostic Use.

  • Only 25 µL of sample is sufficient for the assay
  • Superior sensitivity of 0.135 µIU/mL
  • Dynamic range of 0.15-20 µIU/mL
Species
Human
Regulatory Status
FDA Class I Device. For In Vitro Diagnostic Use.
Product Distribution
Available Worldwide
Range
0.15 - 20 µIU/mL
Sensitivity
0.135 µIU/mL
Sizes
96 Wells
Sample Types
Plasma, Serum
Inc Time Hour
1
Inc Time Minute
30
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
25
Detection
Colorimetric

The Ultrasensitive Insulin ELISA kit is a FDA registered in vitro diagnostic tool for the quantification of human insulin in a clinical setting or research laboratory. The Ultrasensitive Insulin ELISA utilizes a dual-monoclonal antibody sandwich ELISA format, diabetes control, and 96-well microplate comprising removable strips. The Ultrasensitive Insulin ELISA kit has the performance characteristics and flexibility necessary to confidently measure up to 40 samples in duplicate. The shelf-life of the components and the resealable microplate pouch allow for convenient storage for future use if the entire kit is not needed at one time. 

Ultrasensitive Insulin ELISA

80-INSHUU-E01.1

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

ALPCO AAAAI 2024
ALPCO at 2024 American Academy of Allergy, Asthma & Immunology(AAAAI) Annual Meeting
As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.
View Now
Biomarker Monitoring for the Management of Crohn’s Disease
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in...
View Now
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic...
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.